Production (Stage)
Coya Therapeutics, Inc.
COYA
$5.45
-$0.18-3.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -150.59% | 27.49% | -39.07% | 42.76% | -499.04% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.64% | 2.00% | 17.02% | 43.76% | 6.84% |
| Change in Net Operating Assets | 1,263.90% | 86.88% | 5.09% | -134.78% | 270.60% |
| Cash from Operations | -17.37% | 55.88% | -19.67% | -312.67% | 195.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 87.06% |
| Cash from Investing | -- | -- | -- | 100.00% | 87.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.80% | -- | -- | 274.85% | -94.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -99.80% | 17,315.10% | -101.09% | 314.66% | -94.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.57% | 231.98% | -1,042.07% | -82.58% | -84.53% |